Summary:
A Phase III trial for patients diagnosed with AS/ankylosing spondylitis that have either failed traditional NSAID therapy or TNF therapy.
Study medication is administered intravenously/IV in the doctors office monthly.
Qualified Participants Must:
• Have a confirmed diagnosis of AS and currently being treated for AS
•
Have been seen by a physician for AS in the last 12 months
•
Not have HIV, Hep B, Hep C
•
Not be on more than 10mg of corticosteriods per day
•
Not be pregnant or lactating
Qualified Participants May Receive:
Study medication and all health assessments at no cost. Compensation for time and travel.